GP KFPs / SAQs · dermatological-presentations
Psoriasis — KFP-style written assessment
KFP-style staged scenarios on psoriasis: diagnosing variants including guttate and emergencies, psoriatic arthritis and cardiometabolic screening, the topical ladder, phototherapy and systemic escalation, biologic hierarchy from network meta-analysis, and lifestyle co-prescription.
On this page
Study tools
Target exams
RACGP KFPRACGP AKTMRCGP AKT
Prompt
Psoriasis: skin is only the beginning — arthritis, heart, liver and mood travel with it
KFP 1 (10 marks)
A 19-year-old student presents two weeks after a severe sore throat with dozens of drop-like scaly papules across trunk and proximal limbs. This is her first episode. She is otherwise well; throat still mildly sore. [4]
- State the diagnosis, its trigger and the investigation you would order. (3) [4]
- Outline management and prognosis counselling. (4) [4]
- She asks whether she will develop chronic plaque disease or arthritis. Answer honestly. (3) [4]
Model answers
- Guttate psoriasis — widespread drop-like scaly papules on trunk/proximal limbs appearing one to three weeks after streptococcal pharyngitis. Order throat swab ± ASO titre to document streptococcal trigger. [4]
- Many episodes resolve spontaneously over weeks–months; treat symptomatically with emollients and topical corticosteroids ± vitamin D analogue. For extensive or persistent eruptions, NB-UVB phototherapy clears most cases. Treat documented streptococcal infection; discuss tonsillectomy only for recurrent streptococcal-triggered flares. Prognosis counselling: guttate may resolve completely, persist, or transition to chronic plaque disease — follow-up until pattern declares itself. [4]
- A proportion develop chronic plaque psoriasis; some develop psoriatic arthritis. Honest answer: neither is inevitable, but psoriasis is a lifelong tendency — counsel on triggers (streptococcal infection, skin trauma/Koebner, smoking, alcohol, stress) and give explicit advice to return if joints become painful or stiff, since psoriatic arthritis screening belongs at every future review. Family history strengthens both risks. [4] [2]
References6ShowHide
- [1]Elmets CA, Korman NJ, Prater EF et al. Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. Journal of the American Academy of Dermatology, 2021.PMID 32738429
- [2]Elmets CA, Leonardi CL, Davis DMR et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. Journal of the American Academy of Dermatology, 2019.PMID 30772097
- [3]Menter A, Strober BE, Kaplan DH et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. Journal of the American Academy of Dermatology, 2019.PMID 30772098
- [4]Mastorino L, Leo F, Frigatti G et al. Management of Erythrodermic Psoriasis with Systemic Therapies: A Systematic Review. American journal of clinical dermatology, 2025.PMID 40856907
- [5]Lebwohl MG, Merola JF, Rowland K et al. Safety of guselkumab treatment for up to 5 years in patients with moderate-to-severe psoriasis. British Journal of Dermatology, 2023.PMID 37022762
- [6]Sbidian E, Chaimani A, Guelimi R et al. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. The Cochrane database of systematic reviews, 2023.PMID 37436070